NCT01856621
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Orion Pharma Clinical Pharmacology Unit Espoo, Finland
Clinical trial condition
Hypersensitivity
Explore clinical trials studying Hypersensitivity. Study availability and eligibility vary by location and protocol.
6,740 public trials
642 recruiting studies
Hypersensitivity trial results
NCT01766843
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Orion Pharma Clinical Pharmacology Unit Espoo, Finland
NCT02026336
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +10 more
- Locations
-
- Vicente Plaza Barcelona, Spain
NCT00217789
- Conditions
- Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
- Locations
-
- University of Medicine and Dentistry of New Jersey Newark, New Jersey, United States
NCT01233284
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.380.43002 Boehringer Ingelheim Investigational Site Hallein, Austria
- 205.380.43004 Boehringer Ingelheim Investigational Site Linz, Austria
- 205.380.43005 Boehringer Ingelheim Investigational Site Neumarkt am Wallersee, Austria
- 205.380.43001 Boehringer Ingelheim Investigational Site Schlüsslberg, Austria
NCT00350207
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 205.342.43002 Boehringer Ingelheim Investigational Site Graz, Austria
- 205.342.43004 Boehringer Ingelheim Investigational Site Trofaiach, Austria
- 205.342.43001 Boehringer Ingelheim Investigational Site Vienna, Austria
- 205.342.43005 Boehringer Ingelheim Investigational Site Vienna, Austria
NCT00115323
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT00936624
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT00584987
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
Completed
Evaluating Symptom Control in in Allergic Rhinitis at Three Years After Starting Immunotherapy
NCT01777438
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +7 more
- Locations
-
- ORL Leuven, Vlaams-Brabant, Belgium
- UZ Leuven Leuven, Vlaams-brabant, Belgium